Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Sell
33
HART Quote, Financials, Valuation and Earnings
Last price:
$31.00
Seasonality move
:
0.56%
Day range:
$31.18 - $31.20
52-week range:
$28.56 - $34.43
Dividend yield:
1.19%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
397
Avg. volume:
801
1-year change:
9.07%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
HART
NYLI Healthy Hearts ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
HART
NYLI Healthy Hearts ETF
|
$31.18 | -- | -- | -- | $0.06 | 1.19% | -- |
|
AGNG
Global X Aging Population ETF
|
$30.75 | -- | -- | -- | $0.10 | 0.74% | -- |
|
IXJ
iShares Global Healthcare ETF
|
$87.14 | -- | -- | -- | $0.62 | 1.48% | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
$51.65 | -- | -- | -- | $0.33 | 5.45% | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
$23.22 | -- | -- | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
HART
NYLI Healthy Hearts ETF
|
-- | 0.784 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 1.009 | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | 0.894 | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | 0.904 | -- | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
-- | 0.000 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
HART
NYLI Healthy Hearts ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
-- | -- | -- | -- | -- | -- |
NYLI Healthy Hearts ETF vs. Competitors
-
Which has Higher Returns HART or AGNG?
Global X Aging Population ETF has a net margin of -- compared to NYLI Healthy Hearts ETF's net margin of --. NYLI Healthy Hearts ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HARTNYLI Healthy Hearts ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About HART or AGNG?
NYLI Healthy Hearts ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that NYLI Healthy Hearts ETF has higher upside potential than Global X Aging Population ETF, analysts believe NYLI Healthy Hearts ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings HARTNYLI Healthy Hearts ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is HART or AGNG More Risky?
NYLI Healthy Hearts ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.927%.
-
Which is a Better Dividend Stock HART or AGNG?
NYLI Healthy Hearts ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 1.19%. Global X Aging Population ETF offers a yield of 0.74% to investors and pays a quarterly dividend of $0.10 per share. NYLI Healthy Hearts ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HART or AGNG?
NYLI Healthy Hearts ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. NYLI Healthy Hearts ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, NYLI Healthy Hearts ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NYLI Healthy Hearts ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HARTNYLI Healthy Hearts ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns HART or IXJ?
iShares Global Healthcare ETF has a net margin of -- compared to NYLI Healthy Hearts ETF's net margin of --. NYLI Healthy Hearts ETF's return on equity of -- beat iShares Global Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HARTNYLI Healthy Hearts ETF-- -- -- IXJiShares Global Healthcare ETF-- -- -- -
What do Analysts Say About HART or IXJ?
NYLI Healthy Hearts ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Global Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that NYLI Healthy Hearts ETF has higher upside potential than iShares Global Healthcare ETF, analysts believe NYLI Healthy Hearts ETF is more attractive than iShares Global Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings HARTNYLI Healthy Hearts ETF0 0 0 IXJiShares Global Healthcare ETF0 0 0 -
Is HART or IXJ More Risky?
NYLI Healthy Hearts ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Global Healthcare ETF has a beta of 0.671, suggesting its less volatile than the S&P 500 by 32.919%.
-
Which is a Better Dividend Stock HART or IXJ?
NYLI Healthy Hearts ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 1.19%. iShares Global Healthcare ETF offers a yield of 1.48% to investors and pays a quarterly dividend of $0.62 per share. NYLI Healthy Hearts ETF pays -- of its earnings as a dividend. iShares Global Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HART or IXJ?
NYLI Healthy Hearts ETF quarterly revenues are --, which are smaller than iShares Global Healthcare ETF quarterly revenues of --. NYLI Healthy Hearts ETF's net income of -- is lower than iShares Global Healthcare ETF's net income of --. Notably, NYLI Healthy Hearts ETF's price-to-earnings ratio is -- while iShares Global Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NYLI Healthy Hearts ETF is -- versus -- for iShares Global Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HARTNYLI Healthy Hearts ETF-- -- -- -- IXJiShares Global Healthcare ETF-- -- -- --
-
Which has Higher Returns HART or JDOC?
JPMorgan Healthcare Leaders ETF has a net margin of -- compared to NYLI Healthy Hearts ETF's net margin of --. NYLI Healthy Hearts ETF's return on equity of -- beat JPMorgan Healthcare Leaders ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HARTNYLI Healthy Hearts ETF-- -- -- JDOCJPMorgan Healthcare Leaders ETF-- -- -- -
What do Analysts Say About HART or JDOC?
NYLI Healthy Hearts ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand JPMorgan Healthcare Leaders ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that NYLI Healthy Hearts ETF has higher upside potential than JPMorgan Healthcare Leaders ETF, analysts believe NYLI Healthy Hearts ETF is more attractive than JPMorgan Healthcare Leaders ETF.
Company Buy Ratings Hold Ratings Sell Ratings HARTNYLI Healthy Hearts ETF0 0 0 JDOCJPMorgan Healthcare Leaders ETF0 0 0 -
Is HART or JDOC More Risky?
NYLI Healthy Hearts ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison JPMorgan Healthcare Leaders ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HART or JDOC?
NYLI Healthy Hearts ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 1.19%. JPMorgan Healthcare Leaders ETF offers a yield of 5.45% to investors and pays a quarterly dividend of $0.33 per share. NYLI Healthy Hearts ETF pays -- of its earnings as a dividend. JPMorgan Healthcare Leaders ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HART or JDOC?
NYLI Healthy Hearts ETF quarterly revenues are --, which are smaller than JPMorgan Healthcare Leaders ETF quarterly revenues of --. NYLI Healthy Hearts ETF's net income of -- is lower than JPMorgan Healthcare Leaders ETF's net income of --. Notably, NYLI Healthy Hearts ETF's price-to-earnings ratio is -- while JPMorgan Healthcare Leaders ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NYLI Healthy Hearts ETF is -- versus -- for JPMorgan Healthcare Leaders ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HARTNYLI Healthy Hearts ETF-- -- -- -- JDOCJPMorgan Healthcare Leaders ETF-- -- -- --
-
Which has Higher Returns HART or THNR?
Amplify Weight Loss Drug & Treatment ETF has a net margin of -- compared to NYLI Healthy Hearts ETF's net margin of --. NYLI Healthy Hearts ETF's return on equity of -- beat Amplify Weight Loss Drug & Treatment ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HARTNYLI Healthy Hearts ETF-- -- -- THNRAmplify Weight Loss Drug & Treatment ETF-- -- -- -
What do Analysts Say About HART or THNR?
NYLI Healthy Hearts ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Amplify Weight Loss Drug & Treatment ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that NYLI Healthy Hearts ETF has higher upside potential than Amplify Weight Loss Drug & Treatment ETF, analysts believe NYLI Healthy Hearts ETF is more attractive than Amplify Weight Loss Drug & Treatment ETF.
Company Buy Ratings Hold Ratings Sell Ratings HARTNYLI Healthy Hearts ETF0 0 0 THNRAmplify Weight Loss Drug & Treatment ETF0 0 0 -
Is HART or THNR More Risky?
NYLI Healthy Hearts ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Amplify Weight Loss Drug & Treatment ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HART or THNR?
NYLI Healthy Hearts ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 1.19%. Amplify Weight Loss Drug & Treatment ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. NYLI Healthy Hearts ETF pays -- of its earnings as a dividend. Amplify Weight Loss Drug & Treatment ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HART or THNR?
NYLI Healthy Hearts ETF quarterly revenues are --, which are smaller than Amplify Weight Loss Drug & Treatment ETF quarterly revenues of --. NYLI Healthy Hearts ETF's net income of -- is lower than Amplify Weight Loss Drug & Treatment ETF's net income of --. Notably, NYLI Healthy Hearts ETF's price-to-earnings ratio is -- while Amplify Weight Loss Drug & Treatment ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NYLI Healthy Hearts ETF is -- versus -- for Amplify Weight Loss Drug & Treatment ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HARTNYLI Healthy Hearts ETF-- -- -- -- THNRAmplify Weight Loss Drug & Treatment ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 3.99% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 3.9% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 3.97% over the past day.
